Melita Sun Jung is Chief Business Officer at Terns Pharmaceuticals, Inc. (TERN). They have made 1 open-market trade across 1 company since 2024, most recently 2024-11-30.
CIK 0001962407
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $11K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TERN | 2,250 | $119K |
Shares reported on the most recent Form 4, priced at the 2025-02-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TERN | BUY | 2024-11-30 | 2025-02-03 | $5.11 | $11K | -6.8% | -17.1% | -24.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.